The abstract is read at the publisher; the summary is JClub's.
In the multiethnic HELIUS cohort, having elevated LDL-C, Lp(a), and hsCRP together is linked to a 2.44-fold higher incident ASCVD risk over 8.9 years.
- Why it matters: Different biomarkers reflect distinct atherosclerotic pathways, but it was unclear whether combining them improves risk stratification across ethnic groups with different baseline distributions and ASCVD background risk.
- What they did: Among 15,676 participants without prior myocardial infarction or ischemic stroke, Fine-Gray competing-risk models tested quintile and joint elevations of LDL-C, Lp(a), and hsCRP for incident ASCVD, including interaction and added predictive value beyond a PREVENT-ASCVD clinical model.
- The result: Relative risk gradients were consistent across African, European, and South Asian Surinamese participants (P interaction = 0.75), with no additive or multiplicative interaction; adding Lp(a) and hsCRP modestly improved 10-year discrimination (ΔAUC 0.006, P = 0.030) and reclassification (continuous NRI 0.165).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.